The World Health Organization’s Technical Advisory Group recommended on Wednesday that India’s coronavirus vaccine COVAXIN should be granted emergency use listing status.
The Indian first homegrown COVID-19 vaccine was developed by domestic company Bharat Biotech in collaboration with the country’s Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
The two-dose vaccine has estimated to be 77.8% effective in preventing COVID-19 and 93.4% successful in preventing severe cases of coronavirus infection. The latest studies also determined the jab’s efficacy versus the Delta strain at 65.2%.
Speaking to Tunisie Numérique, former diplomat Abdullah al-Obeidi stated that the attack launched by the…
The exchange rate of the Tunisian dinar (TND) in foreign currencies (EUR, US Dollar, CHF…
An Egyptian soldier was killed and another wounded in a clash with Israeli forces at…
Palestinian journalist Wael Dahdouh arrived this afternoon in Tunis where he was welcomed at the…
Italian Defense Minister Guido Crosetto stated on Monday that Israel's actions in Gaza cannot be…
Speaking to Tunisie Numérique, spokeswoman for the Tunisian Red Crescent Buthaina Qaraqba revealed that, with…
This website uses cookies.